Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News


February 26, 2013
Aims to match patients for biomarker oncology trials  Read More »

February 26, 2013
Achieves record 4Q and FY revenue  Read More »

February 25, 2013
Yura to head discovery and development services  Read More »

February 25, 2013
Broadens cloud-based solutions for clinical trial operational efficiencies  Read More »

February 25, 2013
Will combine technologies to evaluate anti-cancer drug  Read More »

February 25, 2013
Postmarketing reports show serious hypersensitivity reactions  Read More »

February 25, 2013
Provenge adds 61 new accounts in the quarter  Read More »

February 22, 2013
Canadan pact aims to advance promising programs  Read More »

February 22, 2013
Aims to advance an immune therapeutic treatment  Read More »

February 22, 2013
Esbriet revenue up 204%  Read More »

February 22, 2013
Kadcyla approved for HER2-positive metastatic breast cancer  Read More »

February 21, 2013
Revenues up 9% in the quarter  Read More »

February 21, 2013
Patel to serve as president  Read More »

February 21, 2013
To develop FISH-based test to identify high-risk CLL patients  Read More »

February 21, 2013
Aims to develop excipients to enhance solubility, bioavailability  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On